def1
AssigneeSmithKline Beecham Corporation
InventorsMichael Arthur Lonetto, Deborah Dee Jaworski, Min Wang, Richard Lloyd Warren, Christopher Michael Traini, Anna Lisa Kosmatka, David Justin Charles Knowles, John Edward Hodgson, Michael Terence Black, David J. Holmes, Richard Oakley Nicholas, Robert King Stodola
Life of this patent
Estimating the term…
Abstract
The invention provides def1 polypeptides and polynucleotides encoding def1 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing def1 polypeptides to screen for antibacterial compounds.
Claims14
An isolated polynucleotide segment comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence encodes a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:
- 2, wherein the first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence is not genomic DNA.
An isolated polynucleotide segment comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence comprises of SEQ ID NO:
- 1, wherein the first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence is not genomic DNA.
An isolated polynucleotide segment comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence encodes a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:
- 2, wherein the first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence is not genomic DNA.
Dependencies are inferred from the claim text.